News and Press - Avicanna

News & Press

Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain

Avicanna Reports Q1 2025 Results and First Profitable Quarter

Avicanna Announces Revocation Of Management Cease Trade Order

Avicanna Reports Full Year 2024 Audited Financial Statement

Avicanna Announces Receipt Of Management Cease Trade Order and Provides Bi-Weekly Status Update

Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine

« Prev 1 2 3 4 5 6 7 Next »